Skip to main content
SpringerLink
Log in

Systemische antimykotische Therapie — Aktueller Stand

  • Conference paper
Book cover Fortschritte der praktischen Dermatologie und Venerologie

Part of the book series: Fortschritte der praktischen Dermatologie und Venerologie ((DERMATOLOGIE,volume 10))

Zusammenfassung

Das Spektrum der systemisch anwendbaren Antimyzetika ist mit Amphotericin B (AMB), 5-Fluorcytosin (5-FC), Miconazol und Ketoconazol sowie Griseofulvin schmal. Jahrzehntelang haben im wesentlichen AMB und Griseofulvin die Möglichkeiten und Grenzen der innerlichen Behandlung von Pilzinfektionen antipodisch markiert [3]: AMB als universales, parenteral und eher kurzzeitig anzuwendendes, dabei hochtoxisches Medikament zur Therapie der oft lebensbedrohenden Systemmykosen; Griseofulvin als peroral einzunehmende, auch bei Langzeitanwendung gut verträgliche Substanz mit der engen Indikation akuter und chronischer Dermatophytosen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ahmed AR (1982) Immunology of human dermatophyte infections. Arch Dermatol 118:521–525

    Article  PubMed  CAS  Google Scholar 

  2. Artis WM, Odle BM, Jones HE (1981) Griseofulvin-resistant dermatophytosis correlates with in vitro resistance. Arch Dermatol 117:16–19

    Article  PubMed  CAS  Google Scholar 

  3. AMA Department of Drugs (1980) Antifungal Agents. In: AMA Drug Evaluations, 4th edn. American Medical Association, Chicago, pp 1353–1368

    Google Scholar 

  4. Blank H (1982) Commentary: Treatment of dermatomycoses with griseofulvin. Arch Dermatol 118:835–836

    Article  Google Scholar 

  5. Cox FW, Stiller RL, South DA, Stevens DA (1982) Oral ketoconazole for dermatophyte infections. J Am Acad Dermatol 6:455–462

    Article  PubMed  CAS  Google Scholar 

  6. DeFelice R, Galgiani JN, Campell SC, Palpant SD, Friedman BA, Dodge RR, Weinberg MG, Lincoln LJ, Tennican PO, Barbee RA (1982) Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study. Am J Med 72:681–687

    Article  PubMed  CAS  Google Scholar 

  7. Dismukes WE (1982) Systemic antifungal agents. Vortr First Annual Postgraduate Workshop on Mycology, September 22, 1982, Evanston. Academy Communications, New York pp 1–7

    Google Scholar 

  8. Dismukes WE, Stamm AM, Graybill JR, Graven PC, Stevens DA, Stiller RL, Sarosi GA, Medoff G, Gregg CR, Gallis HA, Fields BT, Marier RL, Kerkering TA, Kaplowitz LG, Cloud G, Bowles C, Shadomy S (1983) Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases Collaborative Antifungal Study. Ann Intern Med 98:13–20

    Article  PubMed  CAS  Google Scholar 

  9. Dorn M (1982) Ketoconazol-Therapie der Pityriasis versicolor. In: Seeliger HPR, Hauck H (Hrsg) Chemotherapie von Oberflächen-, Organ- und Systemmykosen. Perimed, Erlangen, S 75–79

    Google Scholar 

  10. Faergemann J, Djärv L (1982) Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis 30:542–545

    PubMed  CAS  Google Scholar 

  11. Gisslen H, Hersle K, Mobacken H, Nordin P (1982) Comparative study of ketoconazole and griseofulvin in dermatophytosis of the groin. Curr Ther Res 32:40–44

    Google Scholar 

  12. Götz H (1983) Betrachtungen zum ersten deutschen Nizoral-Symposium vom 27. bis 28. November 1981 in Düsseldorf. Z Hautkr 58:266–272

    Google Scholar 

  13. Götz H (1983) Ersetzt Ketoconazol die Behandlung mit Griseofulvin? Hautarzt 34:194–195

    Google Scholar 

  14. Graybill JR, Craven PC, Donovan W, Matthew EB (1982) Ketoconazole therapy for systemic fungal infections. Inadequacy of standard dosage regimens. Am Rev Respir Dis 126:171–174

    PubMed  CAS  Google Scholar 

  15. Grosso DS, Boyden TW, Pamenter RW, Johnson DG, Stevens DA, Galgiani JN (1983) Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport proteins. Antimicrob Agents Chemother 23:207–212

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Harris R, Jones HE, Artis WM (1983) The role of eccrine sweat in delivery of ketoconazole to human stratum corneum. J Inyest Dermatol 80:314

    Google Scholar 

  17. Hay RJ, Clayton YM (1982) Treatment of chronic dermatophyte infections. The use of ketoconazole in griseofulvin treatment failures. Clin Exp Dermatol 7:611–617

    Article  PubMed  CAS  Google Scholar 

  18. Heel RC, Brogden RN, Carmine A, Morley PA, Speight TM, Avery GS (1982) Ketoconazole: A review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs 23:1–36

    Article  PubMed  CAS  Google Scholar 

  19. Heykants JJP, Woestenborghs RJH, Bisscho MPJM, Merkus JMWM (1982) Distribution of oral ketoconazole to vaginal tissue. Eur J Clin Pharmacol 23:331–333

    Article  PubMed  CAS  Google Scholar 

  20. Janssen PAJ, Symoens J (1983) Hepatic reactions during ketoconazole treatment. Am J Med 74:80–85

    Article  PubMed  CAS  Google Scholar 

  21. Jolly HW, Daily AD, Rex IH, Krupp I, Tromovitch TA, Stegman SJ, Glogau R (1983) A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycosis. Cutis 31:208–213

    PubMed  Google Scholar 

  22. Jones HE (1982) Ketoconazole. Arch Dermatol 118:217–219

    Article  PubMed  CAS  Google Scholar 

  23. Korting HC (1983) Ketoconazol und Leber. Hautarzt 34:193–194

    Google Scholar 

  24. Levine HB (ed) (1982) Ketoconazole in the management of fungal disease. Adis Press, New York Tokyo Sydney Mexico Auckland Hongkong

    Google Scholar 

  25. Lin C, Lim J, DiGiore C, Gural R, Symchowicz S (1982) Comparative bioavailability of a microsize and ultramicrosize griseofulvin formulation in man. J Int Res 10:274–277

    CAS  Google Scholar 

  26. Jorizzo JL (1982) Chronic mucocutaneous candidosis. An update. Arch Dermatol 118:963–965

    Article  PubMed  CAS  Google Scholar 

  27. Meinhof W (1983) Ketoconazol—Wende in der antimykotischen Therapie? Hautarzt 34:155–158

    PubMed  CAS  Google Scholar 

  28. N.N. (1983) 11/2 Jahre Erfahrung mit Ketoconazol—eine Bilanz. Fortschr Med 101: 1196–1198

    Google Scholar 

  29. Petersen EA, Alling DW, Kirkpatrick CH (1980) Treatment of chronic mucocutaneous candidiasis with ketoconazole. Ann Int Med 93:791–795

    Article  PubMed  CAS  Google Scholar 

  30. Polak A, Scholer HJ, Wall M (1982) Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. Chemotherapy 28:461–479

    Article  PubMed  CAS  Google Scholar 

  31. Pont A, Williams PL, Loose DS, Feldman D, Reitz RE, Bochra C, Stevens DA (1982) Keoconazole blocks adrenal steroid synthesis. Ann Int Med 97:370–372

    Article  PubMed  CAS  Google Scholar 

  32. Pont A, Williams PL, Azhar S, Reitz RE, Bochra C, Smith ER, Stevens DA (1982) Ketoconazole blocks testosterone synthesis. Arch Int Med 142:2137–2140

    Article  CAS  Google Scholar 

  33. Rand R, Sober AJ, Olmstead PM (1983) Ketoconazole therapy and exfoliative erythroderma. Arch Dermatol 119:97–98

    Article  PubMed  CAS  Google Scholar 

  34. Rensburg CEJ van, Anderson R, Joone G, Merwe MF van der, Eftychis HA (1983) The effects of ketoconazole on cellular and humoral immune functions. J Antimicrob Chemother 11:49–55

    Article  PubMed  Google Scholar 

  35. Roberts DT (1982) The current status of systemic antifungal agents. Br J Dermatol 106:597–602

    Article  PubMed  CAS  Google Scholar 

  36. Robertson MH, Rich P, Parker F, Hanifin JM (1982) Ketoconazole in griseofulvin-resistant dermatophytosis. J Am Acad Dermatol 6:224–229

    Article  PubMed  CAS  Google Scholar 

  37. Schäfer-Korting M, Korting HC, Dorn M, Mutschler E, Braun-Falco O (1983) Ketoconazole concentrations in human skin blister fluid and plasma. Int J Clin Pharm Ther Toxicol (in press)

    Google Scholar 

  38. Schürmeyer T, Nieschlag E (1982) Ketoconazole-induced drop in serum and saliva testosterone. Lancet 2:1098

    Article  PubMed  Google Scholar 

  39. Seeliger HPR, Hauck H (Hrsg) (1982) Chemotherapie von Oberflächen-, Organ- und Systemmykosen, Perimed, Erlangen

    Google Scholar 

  40. Stratigos I, Zissis NP, Katsambas A, Koumentaki E, Michalopoulos M, Flemetakis A (1983) Ketoconazole compared with griseofulvin in dermatophytoses: a randomized, double-blind trial. Dermatologica 166:161–164

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Michael Dorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universität München, Frauenlobstraße 9-11, D-8000, München 2, Deutschland

    Otto Braun-Falco (o. ö. Professor für Dermatologie und Venerologie Direktor der Dermatologischen Klinik und Poliklinik) & Günter Burg (Professor für Dermatologie und Venerologie Leitender Oberarzt der Dermatologischen Klinik und Poliklinik) (o. ö. Professor für Dermatologie und Venerologie Direktor der Dermatologischen Klinik und Poliklinik) &  (Professor für Dermatologie und Venerologie Leitender Oberarzt der Dermatologischen Klinik und Poliklinik)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Dorn, M. (1983). Systemische antimykotische Therapie — Aktueller Stand. In: Braun-Falco, O., Burg, G. (eds) Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82207-0_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82207-0_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-13075-8

  • Online ISBN: 978-3-642-82207-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation